201 related articles for article (PubMed ID: 31152577)
1. Deficient mismatch repair testing in colorectal cancer: more than just screening for Lynch syndrome.
West NP
Colorectal Dis; 2019 Jun; 21(6):621-622. PubMed ID: 31152577
[No Abstract] [Full Text] [Related]
2. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of screening strategies for Lynch syndrome.
Barzi A; Sadeghi S; Kattan MW; Meropol NJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
[TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome and MYH-associated polyposis: review and testing strategy.
Goodenberger M; Lindor NM
J Clin Gastroenterol; 2011 Jul; 45(6):488-500. PubMed ID: 21325953
[TBL] [Abstract][Full Text] [Related]
6. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
Usha L; Dewdney SB; Buckingham LE
JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347
[No Abstract] [Full Text] [Related]
7. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic.
Dow E; Buchanan DD; Winship IM
Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530
[TBL] [Abstract][Full Text] [Related]
8. Family matters in lynch syndrome.
Kastrinos F; Steyerberg EW
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794515
[No Abstract] [Full Text] [Related]
9. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
[TBL] [Abstract][Full Text] [Related]
10. Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.
Vasen HF; Velthuizen ME; Kleibeuker JH; Menko FH; Nagengast FM; Cats A; van der Meulen-de Jong AE; Breuning MH; Roukema AJ; van Leeuwen-Cornelisse I; de Vos Tot Nederveen Cappel WH; Wijnen JT
Fam Cancer; 2016 Jul; 15(3):429-35. PubMed ID: 26973060
[TBL] [Abstract][Full Text] [Related]
11. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
Kravochuck SE; Church JM
ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
[TBL] [Abstract][Full Text] [Related]
12. Genetic mutation risk calculation in Lynch syndrome inheritance: Evaluating the utility of the PREMM
Aissaoui S; Cartellier C; Seytier T; Giraud S; Calender A
Bull Cancer; 2017 Mar; 104(3):288-294. PubMed ID: 28038733
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.
Tresallet C; Brouquet A; Julié C; Beauchet A; Vallot C; Ménégaux F; Mitry E; Radvanyi F; Malafosse R; Rougier P; Nordlinger B; Laurent-Puig P; Boileau C; Emile JF; Muti C; Penna C; Hofmann-Radvanyi H
Int J Cancer; 2012 Mar; 130(6):1367-77. PubMed ID: 21520036
[TBL] [Abstract][Full Text] [Related]
14. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of DNA mismatch repair-deficient colorectal cancer.
Stadler ZK
Hematol Oncol Clin North Am; 2015 Feb; 29(1):29-41. PubMed ID: 25475571
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond.
Wong HL; Christie M; Gately L; Tie J; Lee B; Semira C; Lok SW; Wong R; Gibbs P
Future Oncol; 2018 Nov; 14(26):2725-2739. PubMed ID: 30004261
[TBL] [Abstract][Full Text] [Related]
17. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
18. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
Hitchins MP
Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
[TBL] [Abstract][Full Text] [Related]
19. Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
Provenzale D; Gupta S; Ahnen DJ; Bray T; Cannon JA; Cooper G; David DS; Early DS; Erwin D; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Hampel H; Ismail MK; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Mayer RJ; Ness RM; Regenbogen SE; Samadder NJ; Shike M; Steinbach G; Weinberg D; Dwyer M; Darlow S
J Natl Compr Canc Netw; 2016 Aug; 14(8):1010-30. PubMed ID: 27496117
[TBL] [Abstract][Full Text] [Related]
20. New genetic test for Lynch syndrome.
Kerr C
Lancet Oncol; 2006 Nov; 7(11):892. PubMed ID: 17099981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
